[PDF] Top 20 Lexicografía plurilingüe de los siglos XVI y XVII

... Men in this cohort had greater disease severity as evidenced by the higher mean total UPDRS score, and a higher rate of PD dementia. This is comparable to fi ndings in other studies even after adjustment for age ... See full document

... female sex, age, exacerbations in the previous six months, CAT, mMRC, self-rated severity of disease, number of comorbid conditions, educational level and BMI with all care related actions that were ... See full document

... The detailed information from each trial was carefully extracted by two authors and was recorded as follows: (1) name of the fi rst author, year of publication and fol- low-up time; (2) study design, study population and ... See full document

... cs related to NMS. The age, sex, duration of PD, concomitant illnesses, and medication use of the surveyed or cared-for PwP were not assessed and are not ...that differences in perception of NMS ... See full document

... be related to anxiety, apathy, motor impairment, pain, and cognitive de fi cits, leading to drastic decreases in the health-related quality of life (QoL) of patients with ... See full document

... ’ s personal behavior. 59 Since cognitive de fi cits observed in PD patients were also found to associate with frontal lobe dysfunction, 60 the possibility that cogni- tive de fi cits might explain ToM ... See full document

... closely related to bradykinesia, 11 resulting in distur- bances on muscle ...’ s muscles to have a distinct pattern from the three-phase pattern presented by healthy ... See full document

... (PANDA study) 46 demonstrated the potential ef fi cacy of the combination of oxycodone with the opioid antagonist naloxone on PRP. Although the primary endpoint (ie, average 24-hr pain scores at 4 months) was not signi fi ... See full document

... and disease duration at the time of diag- nosis, degree of dysfunction, cognitive status, possible comorbidities and drug side ...older patients, ie, over 70 years old, if mild cognitive decline and/or ... See full document

... Ninety male speci fi c pathogen free Sprague Dawley (SD) rats, weighing 250 – 280 g, were from SLAK Laboratory Animal Shanghai, China. All animals were housed in a ventilated, dry, and quiet environment with 12-hour light ... See full document

... to its side effects. Quetiapine and olanzapine should not be considered as fi rst-line medications for PDPsy. Nevertheless, despite our precise methodology, intrinsic defects such as small size and incomplete data limited ... See full document

... Detailed surgical procedure has been presented in our previous study. 17,22 In brief, all patients underwent pre- operative contrast enhanced volumetric T1 and T2- weighted magnetic resonance imaging (MRI) of the ... See full document

... many cases, the categories remained the same from ICD-8 to ICD-10 allowing the categories to be directly combined. In other cases, multiple categories from the ICD-8 tabulation list needed to be combined into one ... See full document

... Speci fi c diagnostic clinical criteria have also been estab- lished for possible and probable PD-associated dementia. 10 Diagnosis of dementia must be based on the presence of de fi cits in at least two of the four core ... See full document

... CD157/BST-1 plays a variety of roles in humoral immune responses; neutrophil transmigration and hemato- poietic stem cell support. 33,34 BST-1 produces cyclic ADP- ribose, which is a second messenger that releases Ca 2+ ... See full document

... factor that was applied in the cohort identi fi cation process. Need factors encompassed cognitive and functional status, walk assessment, clarity of speech, dyskinesia, dysphagia, abusive behavior, insomnia, depressed ... See full document

... between patients and physicians tends to be on motor symptoms, especially tremors, as these were the most bothersome symptoms for patients with PD in this ...in patients with earlier-stage PD, 5 ... See full document

... It is well known that GSK3 β is one of the kinases that phosphorylate Tau. Phosphor GSK3 β Y216, the activated form of GSK3 β , was increased in multiple brain areas including MB, SN, hippocampal DG and CA3 (Figure 4A – ... See full document

... ’ s disease (AD) is the most common cause of dementia, and it exhibits pathological properties such as deposition of extracellular amyloid β (A β ) and abnormally phosphorylated Tau in nerve cells and a ... See full document

... PD patients are treated by a general ...PD patients in their catchment area and therefore a limited experience of the disease and its ...all patients in the survey had been seen by a ... See full document